IYUZEH Drug Patent Profile

✉ Email this page to a colleague

When do Iyuzeh patents expire, and what generic alternatives are available?

Iyuzeh is a drug marketed by Thea Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in twenty-seven countries.

The generic ingredient in IYUZEH is latanoprost. There are twenty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the latanoprost profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Iyuzeh

A generic version of IYUZEH was approved as latanoprost by AMRING PHARMS on March 22^nd, 2011.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for IYUZEH?
What are the global sales for IYUZEH?
What is Average Wholesale Price for IYUZEH?

Summary for IYUZEH

International Patents:	34
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	79
Patent Applications:	6,239
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for IYUZEH
What excipients (inactive ingredients) are in IYUZEH?	IYUZEH excipients list
DailyMed Link:	IYUZEH at DailyMed

Drug patent expirations by year for IYUZEH

Pharmacology for IYUZEH

Drug Class	Prostaglandin Analog

US Patents and Regulatory Information for IYUZEH

IYUZEH is protected by one US patents.

Patents protecting IYUZEH

Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Thea Pharma	IYUZEH	latanoprost	SOLUTION/DROPS;OPHTHALMIC	216472-001	Dec 13, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for IYUZEH

See the table below for patents covering IYUZEH around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Poland	2588078		⤷ Sign Up
Mexico	2012014503	SISTEMA POLIMERICO PARA SUMINISTRAR UNA SOLUCION NO VISCOSA A BASE DE PROSTAGLANDINA, SIN CONSERVADORES. (POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE-FREE PROSTAGLANDIN-BASED NONVISCOUS SOLUTION.)	⤷ Sign Up
Chile	2012003684	Una solucion oftalmica que incluye por lo menos una prostaglandina, un agente solubilizador, un agente gelificador carbomero, un agente inhibidor de la polimerizacion del carbomero y un agente co-gelificador/co-solubilizador, la cual tiene una viscosidad entre 8 y 20 mpa.s y no contiene conservadores antimicrobianos; y frasco que la comprende.	⤷ Sign Up
Canada	2802816	SYSTEME DE DELIVRANCE POLYMERIQUE D'UNE SOLUTION NON VISQUEUSE A BASE DE PROSTAGLANDINE SANS CONSERVATEUR (POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE-FREE PROSTAGLANDIN-BASED NONVISCOUS SOLUTION)	⤷ Sign Up
San Marino	T201400098	Sistema di rilascio polimerico di una soluzione non viscosa a base prostaglandina senza conservante	⤷ Sign Up
Spain	2486793		⤷ Sign Up
Japan	2013532159		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for IYUZEH

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0364417	97C0128	France	⤷ Sign Up	PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
3461484	C202130024	Spain	⤷ Sign Up	PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREIOISOMERO, SAL O SALVADO DEL MISMO EN COMBINACION CON LATANOPROST O UNA SAL DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1502; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1502; DATE OF FIRST AUTHORISATION IN EEA: 20210107
3461484	301101	Netherlands	⤷ Sign Up	PRODUCT NAME: LATANOPROST OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/20/1502 20210108
0364417	C970039	Netherlands	⤷ Sign Up	PRODUCT NAME: [1R-[1 ALPHA (Z),2 BETA(R*),3 ALPHA,5ALPHA]]-7-[3,5-DIHYDROXY-2-(3-HYDROXY-5- FENYLPENTYL)CYCLOPENTYL]-5-HEPTEENZUUR, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN ESTER, IN HET BIJZONDER LATANOPROSTUM; NAT. REGISTRATION NO/DATE: RVG 21304 19970610; FIRST REGISTRATION: SE 12716 19960718
0364417	61/1997	Austria	⤷ Sign Up	PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718
0364417	SPC/GB97/014	United Kingdom	⤷ Sign Up	PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216
3461484	SPC/GB21/033	United Kingdom	⤷ Sign Up	PRODUCT NAME: A COMBINATION OF LATANOPROST AND NETARSUDIL; REGISTERED: UK EU/1/20/1502(FOR NI) 20210107; UK PLGB 16053/0034 20210107
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for IYUZEH

Pharmacology for IYUZEH

Patents protecting IYUZEH

Make Better Decisions: Try a trial or see plans & pricing